NONA BIOSCIENCES Trademark

Trademark Overview


On Wednesday, August 31, 2022, a trademark application was filed for NONA BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the NONA BIOSCIENCES trademark a serial number of 97573031. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, December 5, 2024. This trademark is owned by Nona Biosciences US, Inc.. The NONA BIOSCIENCES trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic preparations for medical purposes; Drug delivery agents in the form of powders, tablets, capsules, solutions, cells and nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Tumor suppressing agents; Pharmaceutical products for the prevention and treatment of cancer; Medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Chemical p...

General Information


Serial Number97573031
Word MarkNONA BIOSCIENCES
Filing DateWednesday, August 31, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, December 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 5, 2023

Trademark Statements


Goods and ServicesDiagnostic preparations for medical purposes; Drug delivery agents in the form of powders, tablets, capsules, solutions, cells and nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Tumor suppressing agents; Pharmaceutical products for the prevention and treatment of cancer; Medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Chemical preparations for pharmaceutical or medical purposes, namely, for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Biological preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Biochemical medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor
NOT AVAILABLE"BIOSCIENCES"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 19, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNona Biosciences US, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWilmington, DE 19801

Party NameNona Biosciences US, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilmington, DE 19801

Trademark Events


Event DateEvent Description
Saturday, September 3, 2022NEW APPLICATION ENTERED
Monday, September 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 16, 2023ASSIGNED TO EXAMINER
Monday, June 26, 2023NON-FINAL ACTION WRITTEN
Monday, June 26, 2023NON-FINAL ACTION E-MAILED
Monday, June 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 31, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 31, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 31, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 16, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 5, 2023PUBLISHED FOR OPPOSITION
Tuesday, September 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 31, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 29, 2024SOU EXTENSION 1 FILED
Monday, April 29, 2024SOU EXTENSION 1 GRANTED
Monday, April 29, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 24, 2024DIVISIONAL REQUEST RECEIVED
Tuesday, September 24, 2024SOU EXTENSION 2 FILED
Tuesday, September 24, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 24, 2024TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, December 4, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 5, 2024DIVISIONAL PROCESSING COMPLETE
Thursday, December 5, 2024SOU EXTENSION 2 GRANTED
Thursday, December 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 5, 2024CORRECTED NOA E-MAILED